Though price cut cards might help alleviate the burden of superior drug costs in the temporary, they do not tackle the systemic issues driving up prescription charges within the U.S. Broader coverage adjustments could tackle the root results in of increasing drug costs, which include not enough transparency in pricing plus the job of intermediaries